Objective: Diffusion-weighted imaging (DWI) conveys temporal as well as anatomic information about brain infarction, and is therefore well suited to identify ischemic injury that has occurred simultaneously, or closely linked in time, with a transient ischemic attack (TIA). We aimed to determine the proportion and clinical characteristics of patients with TIA who harbor infarction(s) on DWI. Methods: Using T2-weighted imaging (T2-WI), fast fluid attenuated inversion recovery (FLAIR), and DWI, we studied 57 consecutive patients presenting with acute focal neurologic symptoms lasting less than 24 h. Results: A hyperintense DWI lesion was identified in a vascular territory appropriate to the symptoms in 27 patients (47%). Lesions judged to be clinically appropriate on T2-WI and FLAIR overlapped with a DWI lesion in 41 and 48% of patients, respectively. Independent predictors of infarction on DWI were previous nonstereotypic TIAs, presentation with motor symptoms, and identified stroke mechanism. Conclusion: DWI establishes that recent infarction occurs in almost half of patients with the clinical syndrome of TIA and this subgroup is more likely to harbor an underlying cardiac or cerebrovascular abnormality.

Keywords:
Diffusion-weighted imaging, Transient ischemic attack, Infarction, Ischemic stroke
1.
National Institute of Neurological Disorders and Stroke: Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21:637–676.
2.
Davis PH, Dambrosia JM, Schoenberg BS, Pritchard DA, Lilienfeld AM, Whisnant JP: Risk factors for ischemic stroke: A prospective study in Rochester, Minnesota. Ann Neurol 1987;22:319–327.
3.
Dennis M, Bamford J, Sandercock P, Warlow C: Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990;21:848–853.
4.
Kaminski HJ, Hlavin ML, Likavee MJ, Schmidley JW: Transient neurologic deficit caused by chronic subdural hematoma. Am J Med 1992;92:698–700.
5.
Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finklestein SP: The clinical spectrum of cerebral amyloid angiopathy: Presentations without lobar hemorrhage. Neurology 1993;43:2073–2079.
6.
Fisher CM: Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci 1980;7:9–17.
7.
Fisher CM: Late-life migraine accompaniments – further experience. Stroke 1986;17:1033–1042.
8.
Fisher CM: Transient paralytic attacks of obscure nature: The question of non-convulsive seizure paralysis. Can J Neurol Sci 1978;5:267–273.
9.
Lee H, Lerner A: Transient inhibitory seizures mimicking crescendo TIAs. Neurology 1990;40:165–166.
10.
The UK TIA Study Group: Intracranial tumours that mimic transient cerebral ischaemia: Lessons from a large multicentre trial. J Neurol Neurosurg Psychiatry 1993;56:563–566.
11.
Grigg MJ, Papadakis K, Nicolaides AN, Al-Kutoubi A, Williams MA, Deacon DF, Sonecha T, Eastcott HH: The significance of cerebral infarction and atrophy in patients with amaurosis fugax and transient ischemic attacks in relation to internal carotid artery stenosis: A preliminary report. J Vasc Surg 1988;2:215–222.
12.
Awad I, Modic M, Little JR, Furlan AJ, Weinstein M: Focal parenchymal lesions in transient ischemic attacks: Correlation of computed tomography and magnetic resonance imaging. Stroke 1986;17:399–403.
13.
Murros KE, Evans GV, Toole JF, Howard G, Rose LA: Cerebral infarction in patients with transient ischemic attacks. J Neurol 1989;236:182–184.
14.
Koudstaal PJ, van Gijn J, Lodder J, et al: Transient ischemic attacks with and without a relevant infarct on computed tomographic scans cannot be distinguished clinically. Arch Neurol 1991;48:916–920.
15.
Fazekas F, Fazekas G, Schmidt R, Kapeller P, Offenbacher H: Magnetic resonance imaging correlates of transient cerebral ischemic attacks. Stroke 1996;27:607–611.
16.
Laloux P, Jamart J, Meurisse H, De Coster P, Laterre C: Persisting perfusion defect in transient ischemic attacks: A new clinically useful subgroup? Stroke 1996;27:425–430.
17.
Bogousslavsky J, Regli F: Cerebral infarct in apparent transient ischemic attack. Neurology 1985;35:1501–1503.
18.
Evans GW, Howard G, Murros KE, Rose LA, Toole JF: Cerebral infarction verified by cranial computed tomography and prognosis for survival following transient ischemic attack. Stroke 1991;22:431–436.
19.
Zukowski AJ, Nicolaides AN, Lewis RT, Mansfield AO, Williams MA, Helmis E, Malouf GM, Thomas D, Al-Kutoubi A, Kyprianou P: The correlation between carotid plaque ulceration and cerebral infarction seen on CT scans. J Vasc Surg 1984;1:782–786.
20.
Waxman SG, Toole JF: Temporal profile resembling TIA in the setting of cerebral infarction. Stroke 1983;14:433–437.
21.
Uehara T, Tabuchi M, Mori E: Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia. Stroke 1999;30:378–382.
22.
Ylikoski A, Erkinjuntti T, Raininko R, Sarna S, Sulkava R, Tilvis R: White matter hyperintensities on MRI in the neurologically nondiseased elderly: Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995;26:1171–1177.
23.
Schmidt R, Hayn M, Fazekas F, Kapeller P, Esterbauer H: Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals: Correlations with plasma concentrations of naturally occurring antioxidants. Stroke 1996;27:2043–2047.
24.
Gonzalez RG, Schaefer PW, Buonanno FS, et al: Diffusion-weighted MR imaging: Diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 1999;210:155–162.
25.
Schlaug G, Siewert B, Benfield A, Edelman RR, Warach S: Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology 1997;49:113–119.
26.
Schwamm LH, Koroshetz WJ, Sorensen AG, Wang B, Copen WA, Budzik R, Rordorf G, Buonanno FS, Schaefer PW, Gonzalez RG: Time course of lesion development in patients with acute stroke: Serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke 1998;29:2268–2276.
27.
Marks MP, de Crespigny A, Lentz D, Enzmann DR, Albers GW, Moseley ME: Acute and chronic stroke: Navigated spin-echo diffusion-weighted MR imaging. Radiology 1996;199:403–408.
28.
Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, Saver JL: Diffusion MRI in patients with transient ischemic attacks. Stroke 1999;30:1174–1180.
29.
Sorensen AG, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH, Huang-Hellinger FR, Reese TG, Weisskoff RM, Davis TL, Suwanwela N, Can U, Moreira JA, Copen WA, Look RB, Finklestein SP, Rosen BR, Koroshetz WJ: Hyperacute stroke: Evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996;199:391–401.
30.
Brennan P, Silman A: Statistical methods for assessing observer variability in clinical measures. BMJ 1992;304:1491–1494.
31.
Mintorovitch J, Moseley M, Chileuitt L, Shimizu H, Cohen Y, Weinstein P: Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med 1991;18:39–50.
32.
Moonen CT, Pekar J, de Vleeschouwer MH, van Gelderen P, van Zijl PC, DesPres D: Restricted and anisotropic displacement of water in healthy cat brain and in stroke studied by NMR diffusion imaging. Magn Reson Med 1991;19:327–332.
33.
Hossmann K, Fischer M, Bockhorst K, Hoehn-Berlage M: NMR imaging of the apparent diffusion coefficient (ADC) for the evaluation of metabolic suppression and recovery after prolonged cerebral ischemia. J Cereb Blood Flow Metab 1994;14:723–731.
34.
Busza AL, Allen KL, King MD, van Bruggen N, Williams SR, Gadian DG: Diffusion-weighted imaging studies of cerebral ischemia in gerbils. Potential relevance to energy failure. Stroke 1992;23:1602–1612.
35.
Mintorovitch J, Yang G, Shimizu H, Kucharczyk J, Chan P, Weinstein P: Diffusion-weighted magnetic resonance imaging of acute focal cerebral ischemia: Comparison of signal intensity with changes in brain water and Na+, K+-ATP ase activity. J Cereb Blood Flow Metab 1994;14:332–336.
36.
Pierpaoli C, Righini A, Linfante I, Tao-Cheng J, Alger J, Di Chiro G: Histopathologic correlates of abnormal water diffusion in cerebral ischemia: Diffusion-weighted MR imaging and light and electron microscopic study. Radiology 1993;189:439–448.
37.
Benveniste H, Hedlund LV, Johnson GA: Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy. Stroke 1992;23:746–754.
38.
Brant-Zawadzki M, Atkinson D, Detrick BS, Bradley WG, Scidmore G: Fluid-attenuated inversion recovery (FLAIR) for assessment of cerebral infarction: Initial experience in 50 patients. Stroke 1996;27:1187–1191.
39.
Engelter ST, Provenzale JM, Petrella JR, Alberts MJ: Diffusion MR imaging and transient ischemic attacks. Stroke 1999;30:2762–2763.
40.
Rordorf G, Koroshetz WJ, Copen WA, Gonzalez G, Yamada K, Schaefer PW, Schwamm LH, Ogilvy CS, Sorensen AG: Diffusion- and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage. Stroke 1999;30:599–605.
41.
Righini A, Pierpaoli C, Alger J, Di Chiro G: Brain parenchyma apparent diffusion coefficient alterations associated with experimental complex partial status epilepticus. Magn Reson Imaging 1994;12:865–871.
42.
Zhong J, Petroff O, Prichard J, Gore J: Changes in water diffusion and relaxation properties of rat cerebrum during status epilepticus. Magn Reson Med 1993;30:241–246.
43.
Latour L, Hasegawa Y, Formato J, Fisher M, Sotak C: Spreading waves of decreased diffusion coefficient after cortical stimulation in the rat brain. Magn Reson Med 1994;32:189–198.
44.
Lauritzen M: Pathophysiology of migraine aura: The spreading depression theory. Brain 1994;117:199–210.
45.
Latour L, Hasegawa Y, Formato J, Fisher M, Sotak C: Spreading waves of decreased diffusion coefficient after cortical stimulation in the rat brain. Magn Reson Med 1994;32:189–198.
46.
Cutrer FM, Sorensen AG, Weisskoff RM, Ostergaard L, Sanchez del Rio M, Lee EJ, Rosen BR, Moskowitz MA: Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998;43:25–31.
47.
Mintorovitch J, Moseley M, Chileuitt L, Shimizu H, Cohen Y, Weinstein P: Comparison of diffusion and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med 1991;18:39–50.
48.
Minematsu K, Li L, Sotak C, Davis M, Fisher M: Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke 1992;23:1304–1311.
49.
Ay H, Buonanno FS, Rordorf G, Schaefer PW, Schwamm LH, Wu O, Gonzalez RG, Yamada K, Sorensen GA, Koroshetz WJ: Normal diffusion-weighted MRI during stroke-like deficits. Neurology 1999;52:1784–1792.
50.
Kistler JP, Ropper AH: Therapy of cerebrovascular disease. Harrison’s Principles of Internal Medicine, ed 9, Update I. New York, McGraw-Hill, 1981, pp 69–90.
51.
Kistler JP, Ropper AH, Heros RC: Therapy of ischemic cerebrovascular disease due to atherothrombosis. Parts 1and 2. N Engl J Med 1984;311:27–33, 100–105.
52.
Hossmann K: Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994;36:557–565.
53.
Kaplan B, Brint S, Tanabe J, Jacewitcz M, Wang X, Pulsinelli W: Temporal thresholds for neocortical infarction in rats subjected to reversible focal ischemia. Stroke 1991;22:1032–1039.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.